Table 3.

Number of patients with adverse events in the modified intent-to-treat population

	Dysport (n = 94)	Botox (n = 94)	P value
Subjects with at least one AE, n (%)	14 (14.9)	19 (20.2)	0.332
AEs by category, n (%)
Severe	0 (0.0)	0 (0.0)	1.000
Moderate	0 (0.0)	1 (1.1)	1.000
Treatment-related	14 (14.9)	19 (20.2)	0.332
Leading to discontinuation	0 (0.0)	0 (0.0)	1.000
AEs by type, n (%)
Neck muscle weakness	9 (9.6)	13 (13.8)	0.388
Dysphagia	6 (6.4)	12 (12.8)	0.070
Pain on neck and shoulder	2 (2.1)	7 (7.4)	0.180
Local pain	2 (2.1)	1 (1.1)	1.000
Neck rigidity	1 (1.1)	1 (1.1)	1.000
Hoarseness	1 (1.1)	1 (1.1)	1.000
Headache	1 (1.1)	0 (0.0)	1.000
Dyspnea	0 (0.0)	1 (1.1)	1.000
Paresthesia	0 (0.0)	1 (1.1)	1.000
Dysarthria	0 (0.0)	1 (1.1)	1.000
Fatigue	0 (0.0)	1 (1.1)	1.000